NDC 68788-4133
Ondansetron 8 mg tablet, orally disintegrating
On the label: Preferred Pharmaceuticals, Inc... It's repackaged: Preferred Pharmaceuticals, Inc.. rebottles it from Glenmark Pharmaceuticals Inc., USA's NDC 68462-158.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Glenmark Pharmaceuticals Limited | Goa, India | Makes it and tests it | Problems found, fixed voluntarilyJun 30, 2026 · 7 inspections, 1 with FDA action |
| Glenmark Pharmaceuticals Limited | Dhar, India | Makes it and tests it | Serious problems, FDA actionFeb 14, 2025 · 8 inspections, 1 with FDA action |
Repackaging site
- Preferred Pharmaceuticals Inc., Anaheim, CA, United States · relabels it
Recalls
- Dec 30, 2025 · Class II · Glenmark Pharmaceuticals Inc., USA
Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.
Lots: Lot #: 19251311, Exp Date April 2027
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Ondansetron: every company that makes it
- Form
- tablet, orally disintegrating, oral
- Strength
- 8 mg
- Approval
- ANDA ANDA078152
- On the market since
- Jun 11, 2026
- Package NDCs
68788-4133-168788-4133-3- Official label
- DailyMed (National Library of Medicine), updated Jun 11, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?